Aclaris Therapeutics, Inc.
ACRS
$1.36
$0.053.82%
Headlines
5/3/2024
-
Simply Wall St
4/30/2024
-
Globe Newswire
4/23/2024
-
PR Newswire
4/13/2024
-
Ticker Report
4/11/2024
-
Zolmax
4/5/2024
-
Zacks Investment Research
4/5/2024
-
Ticker Report
4/3/2024
-
Zolmax
3/30/2024
-
Zolmax
3/26/2024
-
Zolmax
3/26/2024
-
Ticker Report
3/20/2024
-
Zacks Investment Research
3/19/2024
-
Ticker Report
3/14/2024
-
PR Newswire
3/14/2024
-
Zolmax
3/13/2024
-
Stock Options Channel
3/11/2024
-
Ticker Report
3/7/2024
-
Simply Wall St
3/6/2024
-
Ticker Report
3/4/2024
-
Zacks Investment Research
3/4/2024
-
Zacks Investment Research
3/4/2024
-
TipRanks Financial Blog
3/4/2024
-
TipRanks Financial Blog
3/4/2024
-
Zolmax
Filings
Tuesday, February 27, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
Business Description
Aclaris Therapeutics, Inc. a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. The company...
more